Martin Kršák (Martin Krsak)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 26

Top Topics

Replacement Therapy

Respiratory Syndrome Coronavirus

Top Venues

Open forum infectious diseases

Journal of burn care & research : official publication of the American Burn Association

International journal of STD & AIDS

Therapeutic advances in infectious disease

This page only lists publications with an associated author ORCID identifier.

Publications

Scott W Mueller, Kyle C Molina, Brittany Blass, Cameron Gibson, Amber D Kohler, Martin Kršák, Arek J Wiktor
Bone and Skin / Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association (2024)
Leo Knudsen Westgard, Taisuke Sato, William S Bradford, Ellen F Eaton, Finlay Pilcher, Andrew J Hale, Devika Singh, Marlene Martin, Ayesha A Appa, Jaimie P Meyer, Melissa B Weimer, Lydia A Barakat, Uriel R Felsen, Matthew J Akiyama, Jessica P Ridgway, Emily D Grussing, Kinna Thakarar, Amy White, John Mutelayi, Martin Kršák, Brian T Montague, Ank Nijhawan, Harini Balakrishnan, Laura R Marks, Alysse G Wurcel
National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals. Open forum infectious diseases 11 (5) (2024)
Leo Knudsen Westgard, Taisuke Sato, William S Bradford, Ellen F Eaton, Finlay Pilcher, Andrew J Hale, Devika Singh, Marlene Martin, Ayesha A Appa, Jaimie P Meyer, Melissa B Weimer, Lydia A Barakat, Uriel R Felsen, Matthew J Akiyama, Jessica P Ridgway, Emily D Grussing, Kinna Thakarar, Amy White, John Mutelayi, Martin Kršák, Brian T Montague, Ank Nijhawan, Harini Balakrishnan, Laura R Marks, Alysse G Wurcel
National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals. Open forum infectious diseases 11 (5) (2024)
Martin Kršák, Sias Scherger, Matthew A Miller, Vincent Cobb, Brian T Montague, Andrés F Henao Martinez, Kyle C Molina
Substance use disorder-associated infections' treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) - an investigator-initiated single-arm unblinded prospective cohort study. Therapeutic advances in infectious disease 11 (2024)
Daniel B Chastain, Martin Kršák, Andrés F Henao-Martínez
Sex-based differences in treatment approaches and outcomes among patients with mpox: Limitations of real-world data. International journal of STD & AIDS (2024)
Scott W Mueller, Kyle C Molina, Brittany Blass, Cameron Gibson, Amber D Kohler, Martin Kršák, Arek J Wiktor
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association 45 (3) (2024)
Leo Knudsen Westgard, Taisuke Sato, William S Bradford, Ellen F Eaton, Finlay Pilcher, Andrew J Hale, Devika Singh, Marlene Martin, Ayesha A Appa, Jaimie P Meyer, Melissa B Weimer, Lydia A Barakat, Uriel R Felsen, Matthew J Akiyama, Jessica P Ridgway, Emily D Grussing, Kinna Thakarar, Amy White, John Mutelayi, Martin Kršák, Brian T Montague, Ank Nijhawan, Harini Balakrishnan, Laura R Marks, Alysse G Wurcel
National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals. Open forum infectious diseases 11 (5) (2024)
Martin Kršák, Sias Scherger, Matthew A Miller, Vincent Cobb, Brian T Montague, Andrés F Henao Martinez, Kyle C Molina
Substance use disorder-associated infections' treatment with dalbavancin enabling outpatient transition (SUDDEN OUT) - an investigator-initiated single-arm unblinded prospective cohort study. Therapeutic advances in infectious disease 11 (2024)
Daniel B Chastain, Martin Kršák, Andrés F Henao-Martínez
Sex-based differences in treatment approaches and outcomes among patients with mpox: Limitations of real-world data. International journal of STD & AIDS 35 (10) (2024)
Scott W Mueller, Kyle C Molina, Brittany Blass, Cameron Gibson, Amber D Kohler, Martin Kršák, Arek J Wiktor
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association 45 (3) (2024)
Scott W Mueller, Kyle C Molina, Brittany Blass, Cameron Gibson, Amber D Kohler, Martin Kršák, Arek J Wiktor
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association 45 (3) (2024)
Scott W Mueller, Kyle C Molina, Brittany Blass, Cameron Gibson, Amber D Kohler, Martin Kršák, Arek J Wiktor
Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. Journal of burn care & research : official publication of the American Burn Association 45 (3) (2024)
Daniel B Chastain, Martin Kršák, Andrés F Henao-Martínez
Sex-based differences in treatment approaches and outcomes among patients with mpox: Limitations of real-world data. International journal of STD & AIDS 35 (10) (2024)
Scott W Mueller, Brittany Blass, Kyle C Molina, Cameron Gibson, Martin Kršák, Amber D Kohler, Lyndsay Deeter, Jennifer Stalilonis, Arek J Wiktor
Augmented renal function in burn patients: occurrence and discordance with commonly used methods to assess renal function. Journal of burn care & research : official publication of the American Burn Association (2023)
Kyle C Molina, Scott W Mueller, Matthew A Miller, Martin Kršák
Response to Mahatanan and Kang: It's Complicated. Open forum infectious diseases 10 (5) (2023)
Kyle C Molina, Scott W Mueller, Matthew A Miller, Martin Kršák
Response to Mahatanan and Kang: It's Complicated. Open forum infectious diseases 10 (5) (2023)
Pranita D Tamma, Lauren Komarow, Lizhao Ge, Julia Garcia-Diaz, Erica S Herc, Yohei Doi, Cesar A Arias, Owen R Albin, Elie Saade, Loren G Miller, Jesse T Jacob, Michael J Satlin, Martin Kršák, W Charles Huskins, Sorabh Dhar, Samuel A Shelburne Iii, Carol Hill, Keri R Baum, Minal Bhojani, Kerryl E Greenwood-Quaintance, Suzannah M Schmidt-Malan, Robin Patel, Scott R Evans, Henry F Chambers, Vance G Fowler, David Van Duin, null null
Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study. Open forum infectious diseases 9 (11) (2022)
Michael J Rybak, Kyle C Molina, Beatriz Da Silva, Scott W Mueller, Laura Damioli, Martin Kršák, Matthew A Miller, Douglas N Fish
Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success. Open forum infectious diseases 9 (6) (2022)
Randall K Hoover, Martin Kršák, Kyle C Molina, Kairav Shah, Mark Redell
Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties. Open forum infectious diseases 9 (5) (2022)
Alison R Novak, Martin Kršák, Tyree Heath Kiser, Robert T Neumann, Luis Cava Prado, Kyle C Molina, Scott W Mueller
Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients. Open forum infectious diseases 9 (2) (2021)
Martin Kršák, Brian L Harry, Brent E Palmer, Carlos Franco-Paredes
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2. Viral immunology 34 (8) (2021)
Daša Viszlayová, Martin Sojka, Silvia Dobrodenková, Szabolcs Szabó, Ondrej Bilec, Mária Turzová, Juraj Ďurina, Barbara Baloghová, Zoltán Borbély, Martin Kršák
SARS-CoV-2 RNA in the Cerebrospinal Fluid of a Patient with Long COVID. Therapeutic advances in infectious disease 8 (2021)
Martin Kršák, Brian L Harry, Brent E Palmer, Carlos Franco-Paredes
Response to Mishra et al. re "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2". Viral immunology 34 (9) (2021)
Martin Kršák, Taylor Morrisette, Matthew Miller, Kyle Molina, Misha Huang, Laura Damioli, Larissa Pisney, Megan Wong, Eric Poeschla
Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A Review. Pharmacotherapy 40 (5) (2020)
Carlos Franco-Paredes, Katherine Jankousky, Jonathan S Schultz, Jessica Bernfeld, Kimberly Cullen, Nicolas G Quan, Shelley Kon, Peter Hotez, Andrés F Henao Martinez, Martin Kršák
COVID-19 in jails and prisons: A neglected infection in a marginalized population. PLoS neglected tropical diseases 14 (6) (2020)
Michael J Rybak, Matthew A Miller, Brian T Montague, Gerard R Barber, R Brett McQueen, Martin Kršák
Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs. Open forum infectious diseases 6 (7) (2019)